
Sign up to save your podcasts
Or


The team behind one of the most successful Covid-19 vaccines have returned to their original mission: making cancer vaccines. The BioNTech professors say the jab will be with us before 2030. What will it mean for the future of cancer treatment? Who will get them? And if cancer isn't killing us, what will?
This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: thetimes.co.uk/storiesofourtimes.
Guest: Tom Whipple, Science Editor, The Times.
Host: Manveen Rana.
Producer: Olivia Case.
Clips: BBC, ITV, CNBC, Sky News.
This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here.
Hosted on Acast. See acast.com/privacy for more information.
By The Times3.9
182182 ratings
The team behind one of the most successful Covid-19 vaccines have returned to their original mission: making cancer vaccines. The BioNTech professors say the jab will be with us before 2030. What will it mean for the future of cancer treatment? Who will get them? And if cancer isn't killing us, what will?
This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: thetimes.co.uk/storiesofourtimes.
Guest: Tom Whipple, Science Editor, The Times.
Host: Manveen Rana.
Producer: Olivia Case.
Clips: BBC, ITV, CNBC, Sky News.
This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here.
Hosted on Acast. See acast.com/privacy for more information.

268 Listeners

183 Listeners

118 Listeners

181 Listeners

85 Listeners

745 Listeners

176 Listeners

1,015 Listeners

210 Listeners

62 Listeners

20 Listeners

170 Listeners

779 Listeners

5 Listeners

3,858 Listeners

1,314 Listeners

851 Listeners

84 Listeners

454 Listeners

188 Listeners

27 Listeners

149 Listeners

2,536 Listeners

41 Listeners

82 Listeners

18 Listeners

29 Listeners